Our Promise of Action

We are committed to accelerate our journey to become an anti-racist organization as reflected in our listening, our learning, our decisions, our actions, our investments, and our treatment of people and community.

Our Commitment to and Advocacy for Comprehensive Reproductive Healthcare

Spectrum of Services

Learn about the spectrum of services that our department provides for people in our community

Clinical Trials & Research for Gynecologic Cancers

Clinical Trials & Research for Maternal-Fetal Medicine

Philanthropy

You can make a difference. Your contributions will go directly to the Department of Obstetrics and Gynecology for use in Women's Health.

The Department of OBGYN together with our institution are actively taking measures to address structural racism and the resulting health inequities. The current disparities in obstetric and other health outcomes among women of color are extremely disturbing. We are committed to improving outcomes and eliminating the healthcare disparities that exist within our community.

We pledge and are working to diversify our workforce while providing the resources and mentorship to ensure success. We are actively developing programs in which learners and employees will thrive in a diverse, equitable, inclusive and safe environment. We expect all who work here to self-reflect, acknowledge and speak out against any bias, discrimination or racism.

Froedtert & the Medical College of Wisconsin health network launches Maternal Mobile Clinic

2025-04-18

The Froedtert & the Medical College of Wisconsin health network is proud to launch something new. It’s called the Maternal Mobile Clinic — a one-of-a-kind service that brings care into local communities…

Dr. Abbey Merryman, MD, MBA, named ACMO for Obstetrics and Gynecology and vice chair, clinical operations, Department of Obstetrics and Gynecology 

2025-02-01

As Medical College Physicians (MCP) continues to identify key leader roles that enable our specialty practice growth and fulfill the mission, vision, and strategic priorities of the health network, we…

Recent Research led by Chaluvally-Raghavan has Highlighted the Pivotal Role of the Oncostatin M Receptor (OSMR) in Ovarian Cancer

2024-11-28

Recent research led by Chaluvally-Raghavan has highlighted the pivotal role of the oncostatin M receptor (OSMR) in ovarian cancer. Their findings reveal that OSMR is highly expressed in ovarian cancer…